Abstract
AbstractThere is growing evidence of a shared pathogenesis between Alzheimer’s disease and depression. Therefore, we aimed to further investigate their shared disease mechanisms. We made use of publicly available brain-specific eQTL data and gene co-expression networks of previously reported genetic loci associated with these highly comorbid disorders. No direct genetic overlap was observed between Alzheimer’s disease and depression in our dataset, but we did detect six shared brain-specific eQTL genes: SRA1, MICA, PCDHA7, PCDHA8, PCDHA10 and PCDHA13. Several pathways were identified as shared between Alzheimer’s disease and depression by conducting clustering pathway analysis on hippocampal co-expressed genes; synaptic signaling and organization, myelination, development, and the immune system. This study highlights trans-synaptic signaling and synaptoimmunology in the hippocampus as main shared pathomechanisms of Alzheimer’s disease and depression.
Funder
Universitair Medisch Centrum Groningen
Publisher
Springer Science and Business Media LLC
Reference84 articles.
1. Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018;8:1–10.
2. Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impaired in depressive and anxiety disorders. Am J Psychiatry. 2005;162:1171–8.
3. Duthey B. Priority Medicines for Europe and the World “A Public Health Approach to Innovation” Update on 2004 Background Paper 6. 11 Alzheimer Disease and other Dementias. World Health Organization. 2013.
4. World Health Organization. Global action plan on the public health response to dementia 2017-25.
5. Barbe C, Wolak-Thierry A, Jolly D, Novella J-L, Morrone I, Dramé M, et al. Factors associated with quality of life in patients with Alzheimer’s disease. BMC Geriatr. 2018;18:1–9.